Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Calyxt Appoints Dr. Travis Frey as Chief Technology Officer

May 15, 2019 GMT

MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--May 15, 2019--

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, announced today the appointment of Dr. Travis Frey as Chief Technology Officer, effective May 20, 2019. Dr. Frey brings his extensive knowledge in plant biology and biotechnology to a newly created position at the Company. As CTO, Dr. Frey will be responsible for the Research and Development team to propel product development and its pipeline of healthier food ingredients.


“With over 15 years of agricultural industry and technology innovation experience, Travis will be an excellent asset to complement the Calyxt team as we grow and assess our business needs,” said Jim Blome, Chief Executive Officer of Calyxt. “Travis has a well-rounded background in the field, and I’m confident that in partnership with our Chief Science Officer, Prof. Dan Voytas, he will be a critical voice in our continuous evaluation of our food ingredient pipeline.”

Dr. Travis Frey received his B.S. in Horticulture from Penn State University, followed by his M.S. in Plant Breeding and Plant Genetics from University of Wisconsin. He later obtained his Ph.D. in the Plant Biology and Biotechnology Program at the University of Delaware and DuPont/Pioneer and an M.B.A from the University of Chicago – Booth School of Business. Prior to joining Calyxt, Dr. Frey’s most recent role was with WISErg Corporation as their Vice President of Science and Innovation, where he was responsible for developing and championing the science and technology vision, strategy and execution of company initiatives. Dr. Frey’s past experience also includes various positions with Monsanto, including Controlled Environment Facility Director, Global Dicot Transformation Facility Director, Genome Wide Genotyping and Platform Innovation Lead and Trait Integration Innovation Lead.

“I’m thrilled to be joining a company that uses cutting-edge breeding techniques and forward-thinking to stay ahead of the curve when it comes to innovation in its business,” commented Dr. Travis Frey. “I look forward to partnering with Prof. Dan Voytas and contributing my experience to help Calyxt remain at the forefront of developing healthier food ingredients for consumers.”


Kincannon & Reed, a leading executive search firm focused on the food, agribusiness, and biosciences sectors, assisted Calyxt in the recruitment of its Chief Technology Officer.

About Calyxt

Calyxt is committed to making the food you love a healthier choice. The care we take extends beyond nutritional value. We partner with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. We use cutting edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Today oil from our high oleic soybean plants has lower saturated fats than commodity soybean oil. We are also developing high fiber wheat designed to provide an excellent source of daily fiber when incorporated into wheat-based foods. We continuously pursue innovation to deliver good food that is good for you.

Calyxt is located in Roseville, MN, and is listed on the Nasdaq market (ticker: CLXT). For further information please visit our website at www.calyxt.com.

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.

Forward-Looking Statements

This communication may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in Calyxt’s Annual Report on Form 10-K for the year ended December 31, 2018 along with other Calyxt subsequent filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by applicable laws.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190515005953/en/

CONTACT: For further information, please contact:Media contacts

Jennifer Moore, VP Communications

Phone: +1 (917) 580-1088

email:media@calyxt.comInvestor Relations contact

Simon Harnest, VP Corporate Strategy and Finance

Phone: +1 (646) 385-9008




SOURCE: Calyxt, Inc.

Copyright Business Wire 2019.

PUB: 05/15/2019 04:30 PM/DISC: 05/15/2019 04:30 PM